111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
3.770
-0.010 (-0.26%)
Dec 4, 2025, 4:00 PM EST - Market closed
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $32.68 million as of December 4, 2025. Its market cap has decreased by -43.91% in one year.
Market Cap
32.68M
Enterprise Value
-237.98K
1-Year Change
-43.91%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $32.68M, a decrease of -97.07%. That is a compound annual growth rate of -38.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 32.76M | -38.61% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |